Sign Out
Hypersensitivity to the active substance or to any of the excipients listed.
Gastrointestinal haemorrhage, mechanical obstruction or gastrointestinal perforation for which the stimulation of gastrointestinal motility constitutes a risk.
Confirmed or suspected pheochromocytoma, due to the risk of severe hypertension episodes.
History of neuroleptic or metoclopramide-induced tardive dyskinesia.
Epilepsy (increased crises frequency and intensity).
Parkinson's disease.
Combination with levodopa or dopaminergic agonists.
Known history of methaemoglobinaemia with metoclopramide or of NADH cytochrome-b5 deficiency.
Use in children less than 1 year of age.
Continue with Google